Malignant transformation of colonic epithelial cells by a colon-derived long noncoding RNA

Jeffrey L Franklin1, Carl R Rankin, Shawn Levy

  • 1Department of Cell and Developmental Biology, Vanderbilt University, Nashville, TN 37232, United States; Department of Medicine, Vanderbilt University, Nashville, TN 37232, United States; Department of Veterans Affairs Medical Center, Nashville, TN 37232, United States.

Insights

Long non-coding RNAs (lncRNAs) are newly explored in colon health. A specific lncRNA, ncNRFR, drives malignant transformation in colon cells by inhibiting tumor suppressor let-7.

Area of Science:

  • Molecular Biology
  • Genetics
  • Oncology

Background:

  • While protein-coding genes and microRNAs (miRNAs) roles in colonic epithelia are known, long non-coding RNAs (lncRNAs) involvement in colonic homeostasis remains largely uncharacterized.
  • Understanding lncRNA function is crucial for comprehending colonic epithelial cell regulation and disease development.

Purpose of the Study:

  • To investigate the role of lncRNAs in colonic homeostasis.
  • To identify specific lncRNAs expressed in different compartments of the adult mouse colonic crypt.
  • To characterize the function of a novel lncRNA, ncNRFR, in colon cell transformation.

Main Methods:

  • Gene expression profiling of microdissected adult mouse colonic crypts, distinguishing between differentiated tops and proliferative bottoms.
  • Stable overexpression of the identified lncRNA, ncNRFR, in immortalized mouse colonocytes.
  • Assessing malignant transformation through soft agar growth assays and in vivo tumor formation in nude mice.
  • Investigating the interaction of ncNRFR with the tumor suppressor let-7.

Main Results:

  • Several lncRNAs were found to be more highly expressed in the proliferative crypt bottom compartment.
  • A novel lncRNA, non-coding Nras functional RNA (ncNRFR), was identified within the Nras locus.
  • Overexpression of ncNRFR induced malignant transformation of mouse colonocytes, evidenced by anchorage-independent growth and invasive tumor formation.
  • ncNRFR was shown to inhibit the function of the tumor suppressor let-7.

Conclusions:

  • Precise regulation of ncNRFR is essential for normal cell growth and proliferation in the colonic crypt.
  • Misregulation of ncNRFR can lead to neoplastic transformation of colonic epithelial cells.
  • ncNRFR represents a potential therapeutic target for colon cancer.

Related Concept Videos

lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA (lncRNA)...
Non-LTR Retrotransposons03:18

Non-LTR Retrotransposons

As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...